All lobbying filings

STANTON PARK GROUP

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Global biotechnology company

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Lobbyists on this filing 5

JAMES DERDERIAN

Previously held: Chief of Staff, House Commerce Committee; Legislative Advisor to Rep. Tom Bliley
VALERIE HENRY

Previously held: Legislative Director, Rep. Greg Walden; Legislative Assistant to Sen. John Warner and Sen. Mike Crapo
BRYAN WILLIAM WELLS

Previously held: Policy Advisor, Senator Pat Roberts
AISLING MCDONOUGH

Previously held: Chief of Staff, Rep. Anna Eshoo; Senior Health Advisor, Rep. Anna Eshoo; Policy Coordinator, Energy & Commerce Committee; Legislative Assistant, Sen. Brian Schatz
KEVIN DAWSON New on this filing

Previously held: Chief of Staff, Congressman Mike Kelly; Health Policy Advisor, Senator Bill Cassidy; Professional Staff Member, Senate Committee on the Budget

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 1227 and S. 375

Bills named in this filing 2

H.R. 1227
Alternatives to PAIN Act
S. 375
Transition-to-Success Mentoring Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.